Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SVRA
Stock Latest News
Ratings
Savara: Buy Rating Reaffirmed as MOLBREEVI Advances Toward 2026 PDUFA; $10 Price Target Maintained
23h ago
SVRA
Premium
The Fly
Savara reports Q2 EPS (16c), consensus (15c)
2d ago
SVRA
Premium
The Fly
Savara announces EPO granted a patent covering formulation of Molbreevi
14d ago
SVRA
Premium
The Fly
Palvella Therapeutics appoints Savara CEO Matt Pauls to board
1M ago
PVLA
SVRA
Premium
Ratings
Savara Earns Buy Rating on Strengthened Leadership and High Confidence in MOLBREEVI’s Regulatory Path and Commercial Potential
2M ago
SVRA
Premium
Company Announcements
Savara Expands Share Capital and Updates Executive Leadership
2M ago
8K
SVRA
Premium
The Fly
Savara says CFO Dave Lowrance stepping down for health reasons
2M ago
SVRA
Premium
The Fly
Savara presents poster at ATS 2026 International Conference on IMPALA-2
3M ago
SVRA
Premium
The Fly
Savara reports Q1 EPS (15c), consensus (14c)
3M ago
SVRA
Premium
The Fly
Savara assumed with an Outperform at Oppenheimer
4M ago
SVRA
Premium
The Fly
Savara says FDA extended review for Molgramostim BLA
4M ago
SVRA
Premium
Ratings
Savara: Regulatory Momentum and Strong Efficacy Data Support Buy Rating on MOLBREEVI in Autoimmune PAP
4M ago
SVRA
Premium
The Fly
Savara announces MHRA accepted submission of Molbreevi MAA
4M ago
SVRA
Premium
The Fly
Savara announces EMA validation of MAA for MOLBREEVI
5M ago
SVRA
Premium
Ratings
De-Risked Path to Market and Concentrated Rare Disease Opportunity Support Buy Rating on Savara’s Molbreevi
5M ago
SVRA
Premium
Ratings
Savara: Regulatory Momentum and Strong Phase 3 Data Underpin Buy Rating and $11 Upside Target
5M ago
SVRA
Premium
The Fly
Midday Fly By: Adobe CEO to step down, Meta delays ‘Avocado’ AI model launch
5M ago
BX
MS
Premium
Company Announcements
Savara Signs Long-Term Lease for New Headquarters
5M ago
8K
SVRA
Premium
The Fly
Savara reports Q4 EPS (13c), consensus (12c)
5M ago
SVRA
Premium
The Fly
Savara announces receipt of Day 74 Letter from FDA
5M ago
SVRA
Premium
The Fly
Savara says FDA files BLA for Molbreevi
6M ago
SVRA
Premium
The Fly
Savara announces BLA for Molbreevi filed for review by FDA
6M ago
SVRA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
